Xianbin Xu

State Key Laboratory For Diagnosis And Treatment Of Infectious Diseases
Hangzhou, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

Characterization of the intrahepatic microbiome in patients with HBV-related end-stage liver disease.

Characterization of the intrahepatic microbiome in patients with HBV-related end-stage liver disease.

Journal: Virulence

Published: April 27, 2026

Delphi survey to explore core curriculum for training the next-generation of hepatologists☆.

Delphi survey to explore core curriculum for training the next-generation of hepatologists☆.

Journal: JHEP reports : innovation in hepatology

Published: December 10, 2025

Emergency granulopoiesis-linked module activation in PBMC transcriptomes associates with adverse outcomes in HBV-related cirrhosis with acute decompensation.

Emergency granulopoiesis-linked module activation in PBMC transcriptomes associates with adverse outcomes in HBV-related cirrhosis with acute decompensation.

Journal: Journal of hepatology

Published: December 05, 2025

Advancements in Understanding the Role of Oxylipins in Liver Injury and Liver Failure.

Advancements in Understanding the Role of Oxylipins in Liver Injury and Liver Failure.

Journal: Journal of clinical and translational hepatology

Published: September 26, 2025

Applications of Artificial Intelligence and Smart Devices in Metabolic Dysfunction-associated Steatotic Liver Disease.

Applications of Artificial Intelligence and Smart Devices in Metabolic Dysfunction-associated Steatotic Liver Disease.

Journal: Journal of clinical and translational hepatology

Published: August 09, 2025

Single-cell analysis identifies RETN+ monocyte-derived Resistin as a therapeutic target in hepatitis B virus-related acute-on-chronic liver failure.

Single-cell analysis identifies RETN+ monocyte-derived Resistin as a therapeutic target in hepatitis B virus-related acute-on-chronic liver failure.

Journal: Gut

Published: May 29, 2025

Clinical, Microbiological, and Antibiotic Treatment Characteristics of Bacterial Infections in Patients with Liver Cirrhosis in China: A Multicenter Study.

Clinical, Microbiological, and Antibiotic Treatment Characteristics of Bacterial Infections in Patients with Liver Cirrhosis in China: A Multicenter Study.

Journal: Journal of clinical and translational hepatology

Published: May 07, 2025

Validation of the CLIF-SIG score in patients with HBV-related acutely decompensated cirrhosis.

Validation of the CLIF-SIG score in patients with HBV-related acutely decompensated cirrhosis.

Journal: Gut

Published: May 06, 2025

Dissecting the liver inflammation ecosystem identifies annexin A1 as a pro-resolving target for liver failure.

Dissecting the liver inflammation ecosystem identifies annexin A1 as a pro-resolving target for liver failure.

Journal: Hepatology (Baltimore, Md.)

Published: February 24, 2025

Risk factors and prognostic impact of new decompensated events in hospitalized patients with decompensated cirrhosis.

Risk factors and prognostic impact of new decompensated events in hospitalized patients with decompensated cirrhosis.

Journal: BMC gastroenterology

Published: August 25, 2024

A dynamic model to predict early occurrence of acute kidney injury in ICU hospitalized cirrhotic patients: a MIMIC database analysis.

A dynamic model to predict early occurrence of acute kidney injury in ICU hospitalized cirrhotic patients: a MIMIC database analysis.

Journal: BMC gastroenterology

Published: March 09, 2024

The burden and predictors of 30-day unplanned readmission in patients with acute liver failure: a national representative database study.

The burden and predictors of 30-day unplanned readmission in patients with acute liver failure: a national representative database study.

Journal: BMC gastroenterology

Published: January 10, 2024

Showing 1-12 of 20

Last Updated: 09/26/2026